» Articles » PMID: 28738359

Predictors of Subclinical Inflammatory Obesity: Plasma Levels of Leptin, Very Low-Density Lipoprotein Cholesterol and CD14 Expression of CD16+ Monocytes

Overview
Journal Obes Facts
Publisher Karger
Specialty Endocrinology
Date 2017 Jul 25
PMID 28738359
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Predictors of subclinical inflammatory obesity (SIO) can be important tools for early therapeutic interventions in obesity-related comorbidities. Waist circumference (WC) and BMI have different SIO sensitivity. We aimed to i) identify SIO predictors and ii) investigate whether CD16+ monocytes are associated with BMI- (generally) or WC-defined (centrally) obesity.

Methods: Anthropometric and metabolic/endocrine (namely catecholamines, adrenaline and noradrenaline) parameters were evaluated, and CD16+ monocytes were studied by flow cytometry in the peripheral blood from 63 blood donors, and compared and correlated to each other. Multiple linear regression analysis was performed to identify variables that best predict SIO.

Results: CD16+ monocyte counts were similar in BMI and WC groups. CD16+ monocytes from centrally obese (CO) showed a more inflammatory pattern, as compared to non-CO subjects. WC was sensitive to lipidemia and, in CO subjects, lipidemia was associated with a more inflammatory phenotype of CD16+ monocytes. These differences were not noticed between BMI groups. Adrenaline was correlated with CD16+ monocyte expansion with a lower inflammatory pattern. Leptin, very low-density lipoprotein cholesterol (VLDL-C), and CD14 expression of CD16+ monocytes were found to be CO predictors.

Conclusions: WC-, but not BMI-defined obesity, was associated with a more inflammatory pattern of CD16+ monocytes, without monocyte expansion, suggesting that a monocyte maturation process rather than an independent arise of CD16+ monocytes occurs in CO. Thus, in a population with low cardiovascular risk, leptin, VLDL-C, and CD14 expression of CD16+ monocytes predict CO, constituting a putative tool for screening of SIO.

Citing Articles

The role of 27-hydroxycholesterol in meta-inflammation.

Son Y, Choi E, Hwang Y, Kim K Korean J Physiol Pharmacol. 2024; 28(2):107-112.

PMID: 38414393 PMC: 10902588. DOI: 10.4196/kjpp.2024.28.2.107.


Adipocyte- and Monocyte-Mediated Vicious Circle of Inflammation and Obesity (Review of Cellular and Molecular Mechanisms).

Todosenko N, Khaziakhmatova O, Malashchenko V, Yurova K, Bograya M, Beletskaya M Int J Mol Sci. 2023; 24(15).

PMID: 37569635 PMC: 10418857. DOI: 10.3390/ijms241512259.


Bioinformatics and Next-Generation Data Analysis for Identification of Genes and Molecular Pathways Involved in Subjects with Diabetes and Obesity.

Ganekal P, Vastrad B, Kavatagimath S, Vastrad C, Kotrashetti S Medicina (Kaunas). 2023; 59(2).

PMID: 36837510 PMC: 9967176. DOI: 10.3390/medicina59020309.


Cell-free DNA as an obesity biomarker.

Camuzi Zovico P, Gasparini Neto V, Venancio F, Soares Miguel G, Graca Pedrosa R, Kenji Haraguchi F Physiol Res. 2020; 69(3):515-520.

PMID: 32469237 PMC: 8648313. DOI: 10.33549/physiolres.934242.


Dopaminergic Pathways in Obesity-Associated Inflammation.

Leite F, Ribeiro L J Neuroimmune Pharmacol. 2019; 15(1):93-113.

PMID: 31317376 DOI: 10.1007/s11481-019-09863-0.

References
1.
Naylor C, Petri Jr W . Leptin Regulation of Immune Responses. Trends Mol Med. 2016; 22(2):88-98. DOI: 10.1016/j.molmed.2015.12.001. View

2.
Austin P, Steyerberg E . The number of subjects per variable required in linear regression analyses. J Clin Epidemiol. 2015; 68(6):627-36. DOI: 10.1016/j.jclinepi.2014.12.014. View

3.
Deng T, Lyon C, Bergin S, Caligiuri M, Hsueh W . Obesity, Inflammation, and Cancer. Annu Rev Pathol. 2016; 11:421-49. DOI: 10.1146/annurev-pathol-012615-044359. View

4.
Zheng C, Yang Q, Xu C, Shou P, Cao J, Jiang M . CD11b regulates obesity-induced insulin resistance via limiting alternative activation and proliferation of adipose tissue macrophages. Proc Natl Acad Sci U S A. 2015; 112(52):E7239-48. PMC: 4702980. DOI: 10.1073/pnas.1500396113. View

5.
Rogacev K, Ulrich C, Blomer L, Hornof F, Oster K, Ziegelin M . Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J. 2009; 31(3):369-76. DOI: 10.1093/eurheartj/ehp308. View